Duality Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Duality Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,542	Closed	-$940K	–	487
2024 Q1	$940K	Buy	+26,542	New	+$711K	0.09%	343
2023 Q3	–	Sell	-10,950	Closed	-$269K	–	714
2023 Q2	$269K	Buy	+10,950	New	+$352K	0.03%	459
2022 Q3	–	Sell	-48,461	Closed	-$2.87M	–	736
2022 Q2	$2.87M	Buy	48,461 +44,694	+1,186%	+$3.67M	0.28%	119
2022 Q1	$438K	Buy	+3,767	New	+$440K	0.05%	497
2021 Q1	–	Sell	-9,258	Closed	-$886K	–	694
2020 Q4	$886K	Buy	+9,258	New	+$954K	0.07%	366

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Duality Advisers's TNDM Position: Q2 2024 in Review

Duality Advisers sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 26,542 shares — an estimated $940K sold.

Duality Advisers first reported a position in TNDM in Q4 2020 and held it in 5 quarters. The position peaked at $2.87M in Q2 2022. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

Duality Advisers reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
Duality Advisers sold 26,542 Tandem Diabetes Care shares in Q2 2024, an estimated $940K.
Duality Advisers first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 5 quarters.
Duality Advisers's Tandem Diabetes Care position peaked at $2.87M in Q2 2022.
317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.